Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Igm Biosciences Inc (NQ: IGMS )

10.43 +0.97 (+10.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Igm Biosciences Inc

< Previous 1 2 3 4 5 6 Next >
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
– Targeted IL-15/IL-15R IgM antibody to be evaluated for safety and pharmacodynamic effects – 
From IGM Biosciences, Inc.
Via GlobeNewswire
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
IGM Biosciences's Return On Capital Employed Overview
Via Benzinga
IGM Biosciences: Q2 Earnings Insights
  IGM Biosciences (NASDAQ:IGMS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:10 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Analyst Ratings for IGM Biosciences
IGM Biosciences (NASDAQ:IGMS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Did Truist Lower IGM Biosciences' Price Target?
Via Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity... 
Via Benzinga
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations 
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
Via Benzinga
$10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed sharply higher on Thursday, there were a few notable insider trades. 
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
From IGM Biosciences, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Upgrades 
Via Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! Another day of trading lies ahead and we're starting it off with the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
10 Biggest Price Target Changes For Wednesday
Morgan Stanley raised the price target on IGM Biosciences, Inc. (NASDAQ: IGMS) from $25 to $30. IGM Biosciences shares fell 4% to $28.32 in pre-market trading. 
Via Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
53 Biggest Movers From Yesterday
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.